CUAMC
OLMA icon

China Universal Asset Management Company’s Olema Pharmaceuticals OLMA Stock Holding History

China Universal Asset Management Company’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Buy
14,225
+1,207
+9% +$26.9K 0.02% 347
2025
Q4 		$325K Buy
13,018
+987
+8% +$17.6K 0.03% 294
2025
Q3 		$118K Sell
12,031
-1,711
-12% -$10.3K 0.01% 373
2025
Q2 		$58.5K Sell
13,742
-1,150
-8% -$5.13K 0.01% 409
2025
Q1 		$56K Buy
14,892
+2,743
+23% +$13.8K 0.01% 413
2024
Q4 		$70.8K Buy
12,149
+1,135
+10% +$11.3K 0.01% 424
2024
Q3 		$132K Buy
11,014
+4,442
+68% +$56.8K 0.01% 333
2024
Q2 		$71.1K Sell
6,572
-3,990
-38% -$43.3K 0.01% 327
2024
Q1 		$120K Buy
10,562
+4,221
+67% +$54.5K 0.02% 353
2023
Q4 		$89K Buy
+6,341
New +$85.2K 0.02% 298
2022
Q4 		– Sell
-378
Closed -$1K – 437
2022
Q3 		$1K Buy
+378
New +$1.6K ﹤0.01% 404

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

China Universal Asset Management Company's OLMA Position: Q1 2026 in Review

China Universal Asset Management Company increased its Olema Pharmaceuticals (OLMA) stake by 9.3% in Q1 2026, buying an estimated $26.9K and bringing the position to 14,225 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #347.

China Universal Asset Management Company first reported a position in OLMA in Q3 2022 and has held it in 11 quarters since. The position peaked at $325K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • China Universal Asset Management Company held 14,225 shares of Olema Pharmaceuticals worth $212K as of Q1 2026.
  • China Universal Asset Management Company bought 1,207 Olema Pharmaceuticals shares in Q1 2026, an estimated $26.9K.
  • Olema Pharmaceuticals made up 0.02% of China Universal Asset Management Company's portfolio in Q1 2026, its #347 holding.
  • China Universal Asset Management Company first reported a position in Olema Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
  • China Universal Asset Management Company's Olema Pharmaceuticals position peaked at $325K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.